4//SEC Filing
ENDO HEALTH SOLUTIONS INC. 4
Accession 0001209191-14-015862
CIK 0001100962operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:36 PM ET
Size
19.8 KB
Accession
0001209191-14-015862
Insider Transaction Report
Form 4
Spengler William
Director
Transactions
- Disposition to Issuer
Common Stock, par value, $.01 per share
2014-02-28−62,662→ 0 total - Disposition to Issuer
2010 Stock Incentive Plan Restricted Stock Units (RSU)
2014-02-28−6,515→ 0 total - Disposition to Issuer
2004 Stock Incentive Plan Stock Options (NQ)
2014-02-28−5,171→ 0 totalExercise: $23.90Exp: 2018-06-26→ Common Stock (5,171 underlying) - Disposition to Issuer
2007 Stock Incentive Plan Stock Options (NQ)
2014-02-28−8,094→ 0 totalExercise: $23.82Exp: 2020-03-12→ Common Stock (8,094 underlying) - Disposition to Issuer
2007 Stock Incentive Plan Stock Options (NQ)
2014-02-28−10,384→ 0 totalExercise: $16.80Exp: 2019-03-12→ Common Stock (10,384 underlying)
Footnotes (5)
- [F1]On February 28, 2014, Endo Health Solutions, Inc. ("Endo") and Paladin Laboratories Inc. ("Paladin") consummated a transaction under an arrangement agreement pursuant to which each of Endo and Paladin was acquired by a new Irish holding company, Endo International plc ("New Endo"). Under the terms of the arrangement agreement (a) New Endo acquired Paladin pursuant to a plan of arrangement under Canadian law and (b) a newly formed subsidiary of New Endo merged with and into Endo, with Endo as the surviving corporation in the merger (the "Merger") and an indirect wholly owned subsidiary of New Endo. At the effective time of the Merger, each Endo common share was cancelled and converted into the right to receive one New Endo ordinary share. The number here represents shares of Endo disposed of pursuant to the Merger, of which 30,272 have been deferred under Endo Directors Deferred Compensation Plan.
- [F2]These restricted stock units granted on March 12, 2013 under the 2010 Stock Incentive Plan, of which none are vested as of February 28, 2014 with the unvested portion generally vesting 25% annually at each future grant date anniversary through March 12, 2017, were assumed by New Endo in the Merger and converted into New Endo restricted stock units with the same terms and conditions as the original Endo restricted stock units.
- [F3]These non-qualified stock options granted on June 26, 2008 under the 2004 Stock Incentive Plan, which are fully vested as of February 28, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
- [F4]These non-qualified stock options granted on March 12, 2009 under the 2007 Stock Incentive Plan, which are fully vested as of February 28, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
- [F5]These non-qualified stock options granted on March 12, 2010 under the 2007 Stock Incentive Plan, of which 6,071 are vested as of February 28, 2014 with the unvested portion generally vesting 25% per year on each remaining grant date anniversary through March 12, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
Issuer
ENDO HEALTH SOLUTIONS INC.
CIK 0001100962
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001100962
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:36 PM ET
- Size
- 19.8 KB